Skip to main content
. 2014 Apr;58(4):2393–2399. doi: 10.1128/AAC.02669-13

TABLE 2.

Fluoroquinolone MICs of 83 isolates and amino acid changes in their DNA topoisomerase genesa

No. of isolates Amino acid substitution for:
MIC (μg/ml)
ParC
ParE
GyrA
D78 S79 D83 K426 D435 E474 G79 S81 E85 CIP LVX MOX
1 4 2 0.25
3 F 4–8 1–4 0.25–0.5
6 Y 4–8 1–2 0.12–8
3 N 4–8 1–4 0.25–0.5
1 N —‡ —‡ —‡ —‡ —‡ —‡ 8 2 0.5
1 K 8 2 1
1 N F 32 8 4
1 F A 32 16 8
1 F A 64 32 8
31 F F 32–64 16–32 2–8
1 F Y 32 16 2
1 —‡ Y —‡ —‡ —‡ —‡ —‡ F‡ —‡ 32 16 4
5 Y F 32–64 16–32 2–4
1 Y V 32 16 4
2 Y Y 32 16 4
2 F K 32 16 4
2 Y F 32 16 2–4
1 N A 64 32 1
1 N F 32 16 2
1 N —‡ F‡ —‡ 32 16 8
2 F N F 64 32 8
1 F Y Y 64 32 8
1 Y F K 64 32 1
1 F Y K 64 32 4
4 F F K 64 32 4–8
1 Y F Q 64 32 16
2 F N F 128 64 8
1 Y N F 128 64 4
1 Y N F 64 32 64
1 N K Y 32 16 2
1 F Y N V 128 64 8
1 F N F K 128 64 64
a

Only changes involved in resistance are shown. —, no change; ‡, the residue is located in a recombinant gene. Additional amino acid changes, not involved in resistance, were ParC N91D (the isolate with mosaic parC gene), ParE I460V (28 isolates), and GyrA S114G (the three isolates with mosaic gyrA genes). CIP, ciprofloxacin; LVX, levofloxacin; MOX, moxifloxacin.